Dow Jones

44 379,22

0,50%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Galapagos NV (PK) (GLPGF)
Galapagos NV (PK) (GLPGF) Actualités

GLPGF

Galapagos NV (PK) (GLPGF)

Galapagos NV (PK)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:GLPGF

Date	Heure	Source	Titre	Symbole	Société
06/11/2024	14h01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GLPGF	Galapagos NV (PK)
04/12/2023	23h16	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	USOTC:GLPGF	Galapagos NV (PK)
15/06/2023	23h03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:GLPGF	Galapagos NV (PK)
07/06/2023	22h46	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:GLPGF	Galapagos NV (PK)
14/02/2023	19h51	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:GLPGF	Galapagos NV (PK)
02/11/2021	21h45	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:GLPGF	Galapagos NV (PK)
26/10/2021	22h08	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:GLPGF	Galapagos NV (PK)
10/05/2021	18h52	Edgar (US Regulatory)	Schedule 13g	USOTC:GLPGF	Galapagos NV (PK)
26/03/2021	00h11	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:GLPGF	Galapagos NV (PK)
25/09/2020	12h05	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GLPGF	Galapagos NV (PK)
12/11/2013	07h49	GlobeNewswire Inc.	Galapagos subsidiary BioFocus signs agreement with Biogen Idec in scleroderma	USOTC:GLPGF	Galapagos NV (PK)
21/10/2013	18h13	GlobeNewswire Inc.	Galapagos increases share capital through warrant exercises	USOTC:GLPGF	Galapagos NV (PK)
17/10/2013	07h33	GlobeNewswire Inc.	Galapagos presents superior potentiator series for CF	USOTC:GLPGF	Galapagos NV (PK)
16/10/2013	07h44	GlobeNewswire Inc.	Galapagos to present Phase 1 data on FFA2 antagonist GLPG0974 at UEG Week in Berlin	USOTC:GLPGF	Galapagos NV (PK)
16/10/2013	07h34	GlobeNewswire Inc.	Galapagos to present GLPG0634 at ACR	USOTC:GLPGF	Galapagos NV (PK)
30/09/2013	18h46	GlobeNewswire Inc.	Delta Lloyd notify of 9.93% shareholding in Galapagos	USOTC:GLPGF	Galapagos NV (PK)
24/09/2013	14h09	GlobeNewswire Inc.	AbbVie and Galapagos to co-develop cystic fibrosis therapies	USOTC:GLPGF	Galapagos NV (PK)
18/09/2013	18h07	GlobeNewswire Inc.	Galapagos creates new warrant plan	USOTC:GLPGF	Galapagos NV (PK)